COVID-19: exploring the familiar terrain

perspectivas3_mena_et_al

Authors

  • Guillermo Mena Servicio de Medicina Preventiva. Hospital Universitari Germans Trias i Pujol. Badalona. España. Universitat Autónoma de Barcelona. Barcelona. España.
  • Irma Casas Servicio de Medicina Preventiva. Hospital Universitari Germans Trias i Pujol. Badalona. España. Universitat Autónoma de Barcelona. Barcelona. España.
  • María Esteve Servicio de Medicina Preventiva. Hospital Universitari Germans Trias i Pujol. Badalona. España. Universitat Autónoma de Barcelona. Barcelona. España.

Keywords:

COVID-19

Abstract

In 2006, theoretical physicist Brian Greene ended an interview with the New York Times by stating that “exploring the unknown requires tolerance for uncertainty”. In the misinformation pandemic that we are currently experiencing, managing uncertainty has become a challenge for the entire population of the planet. In the new world scenario, physical interaction has been largely replaced by digital contact. It is the greater exposure to networks and media of various kinds that causes misinformation and fear to make their way without too much difficulty in a situation of uncertainty. Since the first case of COVID-19 pneumonia (SARS-CoV-2) occurred in China, around 115,000 people have died and almost three million infected cases have been detected in the world. But also, in just over three months, we know much more about this pathogen thanks to the scientific community and very drastic prevention, containment and mitigation measures have been taken by the governments of many countries. The objective of this document is to summarize aspects already demonstrated that, in the opinion of the authors, represent very interesting starting points to think that the exploration of what is known is also a good strategy to reduce uncertainty.

Downloads

Download data is not yet available.

References

Greene B. The Universe on a String. Oct 2006. The New York Times. Disponible en: https://www.nytimes.com/2006/10/20/opinion/20greenehed.html.

Zhu N, Zhang D, Wang W et al.; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733.

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Disponible en: https://coronavirus.jhu.edu/map.html . Acceso e 13 de abril de 2020.

Frequently Asked Questions: How COVID-19 Spreads [Internet]. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Centers for Disease Control and Prevention. [consultado el 12/04/2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/faq.html.

Ridenhour B, Kowalik JM, Shay DK. Unraveling R0: considerations for public health applications. Am J Public Health. 2014 Feb;104(2):e32-41.

Fauci AS, Lane HC, Redfield RR. Covid-19 - Navigating the Uncharted. N Engl J Med. 2020 Mar 26;382(13):1268-1269.

Delamater PL, Street EJ, Leslie TF et al. Complexity of the Basic Reproduction Number (R(0)). Emerg Infect Dis. 2019 Jan;25(1):1-4.

Brainard J, Hooper L, Pond K et al. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2016 Feb;45(1):102-16.

Van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;NEJMc2004973. doi:10.1056/NEJMc2004973.

Chin AWH, Chu JTS, Perera MRA et al. Stability of SARS-CoV-2 in different environmental conditions. The Lancet Microbe 2020; doi: 10.1016/S2666-5247(20)30003-3.

Actualización no 74. Enfermedad por el coronavirus (COVID-19). 13.04.2020 (datos consolidados a las 21:00 horas del 12.04.2020). Centro de Coordinación de Alertas y Emergencias Sanitarias. Dirección General de Salud Pública, Calidad e Innovación. Ministerio de Sanidad. Gobierno de España. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_74_COVID-19.pdf.

Russell TW, Hellewell J, Jarvis CI et al. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Euro Surveill. 2020 Mar;25(12). doi:10.2807/1560-7917.ES.2020.25.12.2000256.

Bao L, Deng W, Gao H et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. BioRxiv. 2020. https://doi.org/10.1101/2020.03.13.990226.

Wu LP. Wang NCh, Chang Yh et al. Duration of Antibody Responses after Severe Acute Respiratory Syndrome. Emerg Infect Dis. 2007 Oct; 13(10): 1562–1564.

Cochrane iberoamérica. ¿Cuál es el riesgo de reinfección por coronavirus SARS–CoV–2? Accedido el 13 de abril de 2020. Disponible en: https://es.cochrane.org/es/recursos/evidencias-covid-19/¿cuál-es-el-riesgo-de-reinfección-por-coronavirus-sars–cov–2.

Ahn DG, Shin HJ, Kim MH, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011.

Published

2020-05-19

How to Cite

1.
Mena G, Casas I, Esteve M. COVID-19: exploring the familiar terrain: perspectivas3_mena_et_al. Rev Esp Salud Pública [Internet]. 2020 May 19 [cited 2025 Feb. 15];94:4 páginas. Available from: https://ojs.sanidad.gob.es/index.php/resp/article/view/1086

Issue

Section

Perspectivas

Categories

Most read articles by the same author(s)